A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Olaparib Impurity 39 | CAS 458535-34-7 - Request Quote

Picture of Olaparib Impurity 39

Olaparib Impurity 39

SZ CAT No:SZ-O033045
CAS No
458535-34-7
Mol.F.
C12H18N2O2
Mol.Wt.
222.3
Inv. Status
In Stock

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Olaparib Impurity 39 is chemically Piperazine-1,4-diylbis(cyclopropylmethanone). Olaparib Impurity 39 is supplied with detailed characterization data compliant with regulatory guideline. Olaparib Impurity 39 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Olaparib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 458535-34-7

Purchase 458535-34-7

Order 458535-34-7

Enquire 458535-34-7

price of 458535-34-7

458535-34-7 Supplier

458535-34-7 Manufacturer

458535-34-7 Exporter

buy high quality Olaparib Impurity 39

Purchase Olaparib Impurity 39

Olaparib Impurity 39 suppliers

Olaparib Impurity 39 manufacturers

Olaparib Impurity 39 price

Order Olaparib Impurity 39

Enquire Olaparib Impurity 39

Olaparib Impurity 39 cost

Olaparib Impurity 39 Supplier

Olaparib Impurity 39 Distributor

Olaparib Impurity 39 for Method Validation

Olaparib Reference Standard

Olaparib Impurity 39 for ANDA Filing

Olaparib Impurity 39 for Forced Degradation Studies

Olaparib Impurity 39 Identification Standards

Olaparib Impurity 39 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,